Our Team
Our team is led by experienced and senior experts in regulatory affairs, clinical trials and reimbursement.
- Dr. Arthur Brandwood: Founder and Managing Director of Brandwood Biomedical. 26 years industry experience with extensive expertise in Regulatory Affairs, including as Director Devices Registration for TGA, and in evaluation of implantable medical devices.
- Mr. Paul Cohen: 32 years industry experience including 16 years in clinical trials management in global pharmaceuticals development and in diagnostics and implantable medical devices
- Mr. David Harrison: Over 25 years industry experience with extensive experience in regulatory and quality in Asia, having worked in both Tokyo and Beijing for leading international diagnostics and device manufacturers.
- Mr. Laurence Fong: 16 years experience in health technology assessment including as former reimbursement reviewer for Commonwealth Department of Health and Ageing and former Head of Pricing and Market Access with globally renowned consultancy IMS Health.
- Dr. Davey Han Dehui: Over 25 years experience in the healthcare business. Based in Beijing, educated in both China and the USA, with qualifications and experience in medicine, health research and policy, epidemiology, clinical research, quality systems and regulatory affairs. He has worked both in the Chinese Department of Health and major western-based corporations, with deep understanding of Chinese, European and American healthcare systems and corporate cultures.
This leadership is supported by a team of highly trained and qualified consultants experienced in dealing with regulatory agencies and with a focus on practical advice and support which meets our clients’ needs.
Our international networks and resources, and our commitment to continuing education mean that we are up to speed with the latest global regulatory and compliance issues, to ensure the continuing relevance of our service.